Location: Home
  • search
  • go
  • Relate News
  • 12/26/2019Sanofi Files NDA for the World's Atopic Dermatitis Biologic Dupilumab ...
  • 12/26/2019China Lists Lemazolam for Regulation as Class 2 Psychotropic
  • 12/25/2019CDE Solicits Comments on Guidelines for Clinical Protocol of Biosimila...
  • 12/23/2019NMPA Issues the Technical Guidelines for Clinical Comparability Studie...
  • 12/23/2019BeiGene Announces Acceptance of a China sNDA for REVLIMID in Relapsed ...
  • 12/23/2019Amid Trade War, China Lowers Import Tariffs on 850 Products Including ...
  • 12/23/2019Roche Eyes China for Sarepta's DMD Gene Therapy
  • 12/20/2019Chi-Med Gets Priority Review for 'Surufatinib' in China
  • 12/20/2019InxMed Cleared to Initiate Phase I Trial for Anticancer FAK Inhibitor
  • 12/20/2019TRACON, 3D Medicines and Alphamab Enter Partnership for Subcutaneous P...
  • 12/20/2019Wuxi Biologics and Convalife Form Partnership to Develop Innovative An...
  • 12/19/2019Genzyme's Orphan Drug Fabrazyme (Agalsidase Beta) Approved in China
  • 12/19/2019Recent Announcement for A More Effective Intellectual Property Protect...
  • 12/19/2019PHIIC: Data Snapshots of Chinese Pharma Market 2013-2019E
  • 12/19/2019Performance Snapshots of HKSE-Listed Pre-profit Biotech Startups
  • 12/19/2019Shanghai Launches New Policy to Support Building of Research Hospitals
  • 12/18/2019Moffitt Cancer Center CEO, Others Resign Over China Ties
  • 12/18/2019HitGen and Mitsubishi Tanabe Enter Into License Agreement
  • 12/17/2019NMPA/CDE Commits to CDISC Standards
  • 12/17/2019Janssen and Shandong Fontacea Enter Licensing Deal for Anti-IL17A mAb
  • 12/17/2019NHSA Issues Interim Regulation for Government Information Publication
  • 12/17/2019NMPA: China Has Over 1 Mln Registered Pharmacists
  • 12/16/2019NHSA and NHC Issue Joint Notice to Facilitate BMI Access of Negotiated...
  • 12/16/2019NH Reports on Chinese OTC Sleep Aids Market in MAT Q3/2018
  • 12/16/2019BeiGene's Brukinsa Fails to Match AbbVie-J&J Rival Imbruvica in La...
  • 12/16/2019A Few Details on the US-China "Phase One" Trade Deal
  • 12/16/2019The US-China Trade Deal Phase Two - Digital Trade, IP, Cyber Intrusion...
  • 12/13/2019Recent Executive Moves
  • 12/13/2019BeiGene Announces Clinical Data on Anti-PD-1 Tislelizumab in Combo wit...
  • 12/13/2019ZJ Medicine and Ambrx Present Positive Data from a Phase 1a/1b Trial o...
  • Page:130/361 Total number of articles:10826: [First][<<] [128] [129] [130] [131] [132] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group